Skip to main content
OpenTrials
Completed

NCT Number: NCT04639063

Assessment of Surgically Removed Abdominal Wall Endometriomas

A retrospective review of all patients who underwent surgery for an anterior abdominal wall mass which confirmed by pathology examination as an endometrioma will be completely performed. The clinical data will be recorded and pathology report diagnosis will be correlated with the clinical data to assess the possible causes of endometrioma in the women treated in our tertiary hospital and the efficacy of the surgical excision.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year–65 year

Sex eligibility

Female

Study type

Observational

Primary location

Abdulkarim Hasan

Cairo, 11884, Egypt

About this study

Our hospital is a tertiary center for performing Cesarean sections, external endometriosis (Endometrioma) is a challenging complication for this operation, many treatment choices are available and the most common is the surgical excision, however recurrence could be seen after the surgical operation. We assess all patients who underwent surgical excision for abdominal wall endometriomas in our hospital by retrieving the medical files and pathology reports to study the possible age group,causes and duration of endometriomas. Also the rate of enodmetriomas among the previously experienced females with cesarean section operations. Pathological diagnosis tools will be also assessed.

Ethical approval was obtained from the local committee. Results will be statistically assessed using SPSS programm.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female
  • Surgically removed abdominal wall endometrioma

Exclusion criteria

  • Male (very very rare to occur)
  • medically treated enodmetrioma
  • Outside treated patients

Treatment and study plan

Microscopic examination using H&E stained slides

Other

Reexamination of the stained slides of the patients from the hospital archive and adding a CD10 stain when required

Other names: CD10 immunohistochemistry

Primary outcomes

  1. Positive for endometrioma

    Time frame: 1 day

    Presence of endometrial glands and stroma along with hemosidren pigment under microscopic examination, confirms the diagnosis and the case will be calculated and the related clinical data

Sponsors and collaborators

Lead sponsor

Al-Azhar University

Other

Registry information

Official study title

Clinico-pathological Assessment of Surgically Removed Abdominal Wall Endometriomas

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Nov 20, 2020
Registry last updated
Mar 10, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.